Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan

Cancer

Volumn 109, Issue 8, 2007, Pages 1487-1492

  Chang, Chung Hsin ^a,b   Yang, Cheng Ming ^a   Yang, An Hang ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Analgesics nephropathy; Chinese herb nephropathy; Chronic renal failure; Dialysis; Malignancy; Transitional cell carcinoma

Indexed keywords

ANALGESIC AGENT; HERBACEOUS AGENT;

ADULT; AGED; CANCER INCIDENCE; CANCER PATIENT; CHINESE HERB; CHRONIC GLOMERULONEPHRITIS; DIABETES MELLITUS; FEMALE; GLUCOSURIA; HEMATURIA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; RARE DISEASE; RETROSPECTIVE STUDY; REVIEW; SYMPTOMATOLOGY; TAIWAN; TRANSITIONAL CELL CARCINOMA; TREATMENT DURATION; URINARY TRACT CARCINOMA;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS; CARCINOMA, TRANSITIONAL CELL; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TAIWAN; URINARY BLADDER NEOPLASMS;

EID: 34247160849     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22557     Document Type: Review

References (23)

1. Moeller S, Gioberge S, Brown G. ESRD patients in 2001: global overview of patients, treatment modalities and development trends. Nephrol Dial Transplant. 2002;17:2071-2076.
2. Hwang SJ, Yang WC, Hwang SC, Lin HM. Data analysis from the application for uremic major illness card from 2001 to 2003. [Abstract]. Acta Nephrol. 2005;19:376.
3. Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ. Increased incidence of malignancy during chronic renal failure. Lancet. 1975;1:883-886.
4. Port FK, Ragheb NE, Schwarz AG, Hawthorne VM. Neoplasm in dialysis patients: a population-based study. Am J Kidney Dis. 1989;14:119-123.
5. Pecqueux JC, Schwarz A, Dieckmann KP, Offermann G. Cancer incidence in patients on chronic dialysis and in renal transplant recipients. Urol Int. 1990;45:290-292.
6. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet. 2000;35:1886-1887.
7. Jiann BP, Yu CC, Lee YH, Huang JK. Uremia with concomitant urothelial cancer. Br J Urol. 1993;72:458-461.
8. Chen KS, Lai MK, Huang CC, Chu SH, Leu ML. Urologic cancer in Uremic patients. Am J Kidney Dis. 1995;25:694-700.
9. Ou JH, Pan CC, Lin JSN, et al. Transitional cell carcinoma in dialysis patients. Eur Urol. 2000;37:90-94.
10. Wang HB, Hsieh HH, Chen YT, Chiang CY, Cheng YT. The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients. Clin Transplant. 2002;16:410-413.
11. Wu MJ, Lian JD, Yang CR, et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis. 2004;43:1091-1097.
12. Gonwa TA, Corbett WT, Schey HM, Buckalew VM. Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med. 1980;93:249-252.
13. Swindle P, Falk M, Rigby R, Petrie J, Hawley C, Nicol D. Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics. Br J Urol. 1998;81:229-233.
14. Kliem V, Thorn W, Krautzig S. High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation. Transplant Int. 1996;9:231-235.
15. Vanherweghem LJ. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med. 1998;4:9-13.
16. Consyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersels de SC. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis. 1999;33:1011-1017.
17. Nortier JL, Martinez MCM, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342:1686-1692.
18. Chiang HS, Guo HR, Hong CL, Lin SM, Lee GF. The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol. 1993;71:274-278.
19. Chiou HY, Chiou ST, Hsu YH, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol. 2000;153:1686-1692.
20. Department of Health, Excutive Yuan,Republic of China: Cancer Registry Annual Report in Taiwan Area, 2000.
21. Terasawa Y, Suzuki Y, Morita M, Kato M, Suzuki K, Sekino H. Ultrasonic diagnosis of renal cell carcinoma in hemodialysis patients. J Urol. 1994;152:846-851.
22. Yang CS, Lin CH, Chang SH, Hsu HC. Rapidly progressive fibrosing interetitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis. 2000;35:313-318.
23. Chang CH, Wang YM, Yang AH, Chiang SS. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol. 2001;21:441-448.